Last €3.83 EUR
Change Today +0.127 / 3.43%
Volume 14.3K
ECX On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 1:19 PM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ann Clare Kessler Ph.D.

Deputy Chairwoman of Supervisory Board, Epigenomics AG
AgeTotal Calculated CompensationThis person is connected to 37 board members in 3 different organizations across 4 different industries.

See Board Relationships
70€32,000

Background*

Dr. Ann Clare Kessler, Ph.D. served as a Director of International Project Management of F. Hoffman-La Roche Ltd. until 1995 and was responsible for global project development decisions. Dr. Kessler has 27 years of full-time pharmaceutical industry experience in the United States and Europe with Hoffmann- La Roche. She served as Vice President, Director of Division of Exploratory Research and Director of Departments of Pharmacology, Chemotherapy and Biochemical Nutrition. ...

Read Full Background

Corporate Headquarters*

Kleine Präsidentenstrasse 1
Berlin, -- 10178

Germany

Phone: 49 30 243 450
Fax: 49 30 2434 5555

Board Members Memberships*

Director
1999-2005
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director

Education*

MS 1967
Northwestern University
PhD 1973
New York University
BS 1965
College Of Notre Dame Of Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€32,000
Total Calculated Compensation€32,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECX:GR €3.83 EUR +0.127

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EPIGENOMICS AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.